Use of USPIO-induced magnetic susceptibility artifacts to identity sentinel lymph nodes and lymphatic drainage patterns. I. Dependence of artifact size with subcutaneous combidexρ dose in rats

Magnetic Resonance Imaging

Volumn 16, Issue 8, 1998, Pages 917-923

  Rogers, James M ^a   Jung, Chu W ^a   Lewis, Jerome ^a   Groman, Ernest V ^a  

^a Advanced Magnetics Inc   (United States)

Author keywords

Combidex; Lymphography; Nanoparticle; Sentinel lymphnode; USPIO

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ARTIFACT; AXILLARY LYMPH NODE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; LYMPH NODE; LYMPHATIC DRAINAGE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ARTIFACTS; AXILLA; CONTRAST MEDIA; IRON; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; OXIDES; RATS;

EID: 0031769086     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(98)00090-3     Document Type: Article

References (24)

1. Vassallo, P.; Matei, C.; Heston, W.D.W.; McLachlan, S.J.; Koutcher, J.A.; Castllino, R.A. AMI-227-enhanced MR lymphography: Usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 193:501-506; 1994.
2. Anzai, Y.; Blackwell, K.E.; Hirschowitz, S.L.; Rogers, J.W.; Sato, Y.; Yuh, W.T.C.; Runge, V.M.; Morris, M.R.; McLachlan, S.J.; Lufkin, R.B. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 192:709-715; 1994.
3. Weissleder, R.; Elizondo, G.; Josephson, L.; Compton, C.C.; Fretz, C.J.; Stark, D.D.; Ferrucci, J.T. Experimental lymph nodes metastases: enhanced detection with MR Lymphography. Radiology 171:835-839; 1989.
4. Adler, L.P.; Faulhaber, P.F.; Schnur, K.C.; Al-Kasi, N.L.; Shenk, R.R. Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 203:323-327; 1997.
5. Mussurakis, S.; Buckley, D.L.; Horsmman, A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 203: 317-321; 1997.
6. Kapteijn, B.A.E.; Nieweg, O.E.; Valdes Olmos, R.A.; Liem, I.H.; Panday, R.K.L.B.; Hoefnagel, C.A.; Kroon, B.B.R. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J. Nucl. Med. 37:972-975; 1996.
7. Wanebo, H.J.; Harpole, D.; Teates, C.D. Radionuclide lymphoscintigraphy with technetium 99 m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk. Cancer 55:1403-1413; 1985.
8. Uren, R.F.; Howman-Giles, R.; Thompson, J.F.; Shaw, H.M.; Quinn, M.J.; O'Brein, C.J.; McCarthy, W.H. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res. 4:395-399; 1994.
9. Munz, D.L.; Altmeyer, P.; Sessler, M.J.; Hor, G. Axillary lymph node groups-the center in lymphatic drainage from the truncal skin in man. Clinical significance for management of malignant melanoma. Lymphology 15:143-147; 1982.
10. Uren, R.F.; Howmann-Giles, R.B.; Thompson, J.F.; Malouf, D.; Ramsey-Stewart, G.; Niesche, F.W.; Renwick, S.B. Mammary lymphoscintigraphy in breast cancer. J. Nucl. Med. 36:1775-1780; 1995.
11. Weissleder, R.; Heautot, J.F.; Schaffer, B.K.; Nossiff, N.; Papisov, M.; Bogdanov, A.J.; Brady, T. MR lymphography: study of 9 high-efficiency lymphotropic agent. Radiology 191:225-230; 1994.
12. 1-type MR contrast agent: 6d-DTPA-P6M. Magn. Res. Med. 33:88-92; 1995.
13. Jung, C.W.; Weissleder, R.; Josephson, L.; Bengele, H.; Brady, T.J. Physical properties of MION-46 and AMI-227. In: Proceedings of the International Society for Magnetic Resonance in Medicine, Fourth Scientific Meeting and Exhibition, Vol. 3. Berkeley, CA: SMRM; 1996:1681.
14. Weissleder, R.; Elizondo, G.; Wittenberg, J.; Lee, A.S.; Josephson, L.; Brady, T.J. Ultrasmall superparamagnetic iron oxide: An i.v. contrast agent for assessing lymph nodes with MR imaging. Radiology 175:494-498; 1990.
15. Hamm, B.; Taupitz, M.; Hussmann, P.; Wagner, S.; Wolf, K.-J. MR lymphography with iron oxide particles: Dose-response studies and pulse sequence optimization in rabbits. AJR 158:183-190; 1992.
16. Hung, J.C.; Wiseman, G.A.; Wahner, H.W.; Mullan, B.P.; Taggart, T.R.; Dunn, W.L. Filtered technetium-99 m-sulfur colloid evaluated for lymphoscintigraphy. J. Nucl. Med. 36:1895-1901; 1995.
17. Ross, M.I. Surgical management of stage I and II melanoma patients: Approach to the regional lymph node basin. Semin. Surg. Oncol. 12:394-401; 1996.
18. Albertini, J.J.; Lyman, G.H.; Cox, C.; Yeatman, T.; Balducci, L.; Ku, N.; Shivers, S.; Berman, C.; Wells, K.; Rapaport, D.; Shons, A.; Horton, J.; Greenberg, H.; Nicosia, S.; Clark, R.; Cantor, A.; Reintgen, D.S. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822; 1996.
19. Palmacci, S.; Josephson, L. Synthesis of polysaccharide covered superparamagnetic oxide colloids. U. S. Patent #5262176. November 16, 1993.
20. Institute of Laboratory Animal Resources, Commission of Life Sciences, National Research Council. Guide for care and use of laboratory animals. Washington, D.C.: National Academic Press; 1996.
21. Bengele, H.H.; Palmacci, S.; Rogers, J.; Jung, C.W.; Crenshaw, C.; Josephson, L. The Biodistribution of the USPIO BMS 180549 by radioactive studies. Magn. Reson. Imaging 12:1161-1165; 1994.
22. Kim, J.K.; Kucharczyk, W.; Henkelman, R.M. Cavernous hemangiomas: Dipolar susceptibility artifacts at MR imaging. Radiology 187:735-42; 1993.
23. Bakker, C.J.G.; Bhagwandien, R.; Moerland, M.A.; Ramos, L.M.P. Simulation of susceptibility artifacts in 2D and 3D Fourier transform spin-echo and gradient-echo magnetic resonance imaging. Magn. Reson. Imaging 12: 767-774; 1994.
24. Tilney, N. Patterns of lymphatic drainage in the adult laboratory rat. J. Anat. 109:369-383; 1971.